Keywords
foetus
congenital infections
nonimmune hydrops fetalis
diagnosis
parvovirus B19
Abstract
Parvovirus B19 (B19V) is a widespread pathogen causing infection that occurs mostly in children. Even though infection of B19V is mainly asymptomatic, it can bring about a few conditions that may require medical intervention, including erythema infectiosum (fifth disease), slapped cheek syndrome, papular-purpuric gloves and socks syndrome (PPGSS), as well as other disorders related to the hematological system. Despite the fact that the most common route of transmission is through the respiratory system, B19V can be also transmitted transplacentally from mother to foetus. Vertical transmission may lead to myocarditis, thrombocytopenia, neural manifestations, and foetal hydrops, which may be life-threatening conditions to both mother and foetus. Detection of B19V infection is based mostly on molecular and serological screening and it is performed after suspected exposure to pathogen or exhibition of symptoms. Currently, there is no specific medication against B19V infection, therefore, treatment is based on the elimination of symptoms. New therapies are, however, under development.References
1. Young NS, Brown KE. Mechanisms of disease: Parvovirus B19. N Engl J Med. 2004;350(6):586-97.
2. Sim JY, Chang LY, Chen JM, Lee PI, Huang LM, Lu CY. Human parvovirus B19 infection in patients with or without underlying diseases. J Microbiol Immunol Infect. 2019;52(4):534-41.
3. Servey JT. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007;75:373-6.
4. Brown KE. Parvoviruses. In: Viral infections of humans: Epidemiology and control. Springer US; 2014:629-49.
5. Ornoy A, Ergaz Z. Parvovirus B19 infection during pregnancy and risks to the fetus. Birth Defects Res. 2017;109:311-23.
6. de Jong EP, Walther FJ, Kroes ACM, Oepkes D. Parvovirus B19 infection in pregnancy: New insights and management. Prenat Diagn. 2011;31:419-25.
7. Seitz R. Parvovirus B19-revised. Transfus Med Hemotherapy. 2010;37:339-50.
8. Dijkmans AC, De Jong EP, Dijkmans BAC, Lopriore E, Vossen A, Walthere FJ, et al. Parvovirus B19 in pregnancy: Prenatal diagnosis and management of fetal complications. Curr Opin Obstet Gynecol. 2012;24:95-101.
9. Soltani S, Zakeri A, Tabibzadeh A, Zandi M, Ershadi E, Akhavan Rezayat S, et al. A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients. Trop Med Health. 2020;48(1):96.
10. Landry ML. Parvovirus B19. Microbiol Spectr. 2016;4(3).
11. Manaresi E, Gallinella G. Advances in the development of antiviral strategies against parvovirus B19. Viruses. 2019;11(7):659.
12. Servant-Delmas A, Morinet F. Update of the human parvovirus B19 biology. Transfus Clin Biol. 2016;23(1):5-12.
13. Crane J, Mundle W, Boucoiran I, Gagnon R, Bujold E, Basso M, et al. Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Canada. 2014;36(12):1107-16.
14. Lamont RF, Sobel JD, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, et al. Parvovirus B19 infection in human pregnancy. Int J Obstet Gynaecol. 2011;118:175-86.
15. Rosenstein RK, Rosenstein PK, Kramer N, Rosenstein ED. Healthcare-associated transmission of parvovirus B19 arthropathy. Bull Hosp Joint Dis. 2020;78(2):140-3.
16. Ismail KM, Kilby MD. Human parvovirus B19 infection and pregnancy. Obstet Gynaecol. 2003;5(1):4-9.
17. Tidman ASM, Fatima R. An unusual cutaneous manifestation of parvovirus B19 infection: papular – purpuric gloves-and-socks syndrome and petechial bathing trunk eruption. Clin Exp Dermatol. 2020;45:341-2.
18. Family A, Allmon A, Deane K, Martin KL. Common skin rashes in children. Am Fam Physician. 2015;92. [http://www.aafp.org/afp]
19. Carlesimo M, Palese E, Mari E, Panasiti V, Picarelli A, Rossi A, et al. Gloves and socks syndrome caused by parvovirus B19 infection. Dermatol Online J. 2006;12(6):19.
20. Santonja C, Nieto-González G, Santos-Briz Á, De Las Nieves Gutiérrez Zufiaurre M, Cerroni L, Kutzner H, et al. Immunohistochemical detection of parvovirus B19 in “gloves and socks” papular purpuric syndrome: Direct evidence for viral endothelial involvement. Report of three cases and review of the literature. Am J Dermatopathol. 2011;33(8):790-5.
21. Ware AJ, Moore T. Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32(7):E122-3.
22. Izquierdo-Blasco J, Salcedo Allende MT, Codina Grau MG, Gran F, Martínez Sáez E, Balcells J. Parvovirus B19 myocarditis: Looking beyond the heart. Pediatr Dev Pathol. 2020;23(2):158-62.
23. Verdonschot J, Hazebroek M, Merken J, Debing Y, Dennert R, Brunner-La Rocca HP, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail. 2016;18:1430-41.
24. Molina KM, Garcia X, Denfield SW, Fan Y, Morrow WR, Towbin JA, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol. 2013;34(2):390-7.
25. Bihari C, Rastogi A, Saxena P, Rangegowda D, Chowdhury A, Gupta N, et al. Parvovirus B19 associated hepatitis. Hepat Res Treat. 2013;2013:1-9.
26. Watanabe T. Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children. World J Clin Pediatr. 2015;4(4):126.
27. Barah F, Whiteside S, Batista S, Morris J. Neurological aspects of human parvovirus B19 infection: A systematic review. Rev Med Virol. 2014;24:154-68.
28. Shimohata H, Higuchi T, Ogawa Y, Fujita S, Nagai M, Imaizumi M, et al. Human parvovirus B19-induced acute glomerulonephritis: A case report. Ren Fail. 2013;35(1):159-62.
29. Karami A, Hoseini SL, Ramazani A, Emadi P, Gholami H, Hoseini SM. Prevalence of Parvovirus B19 infection by serology and PCR in pregnant women referring to Obstetrics and Gynecology Clinic. J Natl Med Assoc. 2020;112(1):91-6.
30. Giorgio E, De Oronzo MA, Iozza I, Di Natale A, Cianci S, Garofalo G, et al. Parvovirus B19 during pregnancy: a review. J Prenat Med. 2010;4(4):63-6.
31. Bonvicini F, Bua G, Gallinella G. Parvovirus B19 infection in pregnancy – awareness and opportunities. Curr Opin Virol. 2017;27: 8-14.
32. Barlinn R, Trogstad L, Rollag H, Frøen F, Magnus P, Dudman SG. Parvovirus B19 DNAemia in pregnant women in relation to perinatal death: A nested case-control study within a large population-based pregnancy cohort. Acta Obstet Gynecol Scand. 2020;99(7):856-64.
33. Attwood LO, Holmes NE, Hui L. Identification and management of congenital parvovirus B19 infection. Prenat Diagn. 2020;40:1722-31.
34. Markowska A, Połczyńska-Kaniak E. Zakażenie parwowirusem B19 w czasie ciąży. Ginekol Dypl. 2011;(4):31-7.
35. Silingardi E, Santunione AL, Rivasi F, Gasser B, Zago S, Garagnani L. Unexpected intrauterine fetal death in parvovirus B19 fetal infection. Am J Forensic Med Pathol. 2009;30(4):394-7.
36. Grabarczyk P, Kalińska A, Litwińska B, Celewicz Z, Dębska M, Nowakowska D, et al. Diagnostyka laboratoryjna zakażenia parvo-wirusem B19 u kobiet w ciąży. Warszawa: Krajowa Izba Diagnostów Laboratoryjnych; 2014.
37. Melamed N, Whittle W, Kelly EN, Windrim R, Seaward PGR, Keunen J, et al. Fetal thrombocytopenia in pregnancies with fetal human parvovirus-B19 infection. Am J Obstet Gynecol. 2015;212(6): 793.e1-793.e8.
38. Pawelec K, Zdziechowicz I, Siwicka A, Matysiak M. Parwowirus B19 jako przyczyna przejściowej anemii aplastycznej – opis przypadku. Postępy Nauk Med. 2016;8:581-3.
39. Costa ML, de Moraes Nobrega G, Antolini-Tavares A. Key Infections in the placenta. Obstet Gynecol Clin N Am. 2020;47:133-46.
40. Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F. Human parvovirus B19: A review. Acta Virologica. 2014;58:199-213.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2022 Authors